Literature DB >> 19862691

Looking past the obvious: experiences of altered masculinity in penile cancer.

Kathryn Bullen1, Stephen Edwards, Victoria Marke, Sarah Matthews.   

Abstract

OBJECTIVES: Penile cancer, although statistically rare in Western countries (1:100 000 per year), results in considerable physical and psychological morbidity. The treatment of choice for penile cancer is either partial or total amputation of the penis. Metastatic spread into the surrounding lymphatic system may require additional surgery. To date, little is known of the lived experiences of men with penile cancer regarding the impact of the disease and its treatment on dimensions of masculinity.
METHODS: A small-scale qualitative study using Interpretative Phenomenological Analysis (IPA). IPA aims at exploring the experience of life events and the meaning and implications for the person living through them. A purposive sample of men with penile cancer who were within a minimum of 18 months post-surgery were recruited via a specialist urology clinic (n = 9). Participants were interviewed by a male researcher using a pre-agreed semi-structured interview schedule; interviews were audio recorded for transcription with detailed analyses of main and sub-themes conducted independently by three researchers. To maintain analytical rigour, constant comparisons of main and sub-themes were made between the individual transcripts and across the emergent themes within the research group.
RESULTS: Central themes were (1) grappling with reality; (2) learning to cope and (3) changes to self.
CONCLUSIONS: That men should have an altered sense of masculine identity following penile cancer surgery is not unexpected. However, the ways in which altered masculinity manifested itself were both subtle and insidious. The results have implications for clinical practice and demonstrated the need for further research. (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 19862691     DOI: 10.1002/pon.1642

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  8 in total

Review 1.  Management of combat-related urological trauma in the modern era.

Authors:  Molly Williams; James Jezior
Journal:  Nat Rev Urol       Date:  2013-07-23       Impact factor: 14.432

Review 2.  Vascularized composite allotransplantation of the penis: current status and future perspectives.

Authors:  Alisa O Girard; Isabel V Lake; Christopher D Lopez; Richa Kalsi; Gerald Brandacher; Damon S Cooney; Richard J Redett
Journal:  Int J Impot Res       Date:  2021-10-28       Impact factor: 2.896

3.  Mental Health in Urologic Oncology.

Authors:  Danyon Anderson; Abrahim N Razzak; Matthew McDonald; David Cao; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-08-20

4.  Dyadic Aspects of Sexual Well-Being in Men with Laser-Treated Penile Carcinoma.

Authors:  Elisabet Skeppner; Kerstin Fugl-Meyer
Journal:  Sex Med       Date:  2015-06       Impact factor: 2.491

5.  Sexual Function after Partial Penectomy: A Prospectively Study From China.

Authors:  Cui Yu; Chen Hequn; Liu Longfei; Chen Minfeng; Chen Zhi; Zeng Feng; Chen Jinbo; Qi Lin; Zu Xiongbing
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

6.  Quality of life in penile carcinoma patients - post-total penectomy.

Authors:  Roman Sosnowski; Marta Kulpa; Mariola Kosowicz; Jan Karol Wolski; Olga Kuczkiewicz; Katarzyna Moskal; Michał Szymański; Tomasz Kalinowski; Tomasz Demkow
Journal:  Cent European J Urol       Date:  2016-06-20

Review 7.  Contemporary role of radiotherapy in the management of penile cancer.

Authors:  Martin Arthur Korzeniowski; Juanita Mary Crook
Journal:  Transl Androl Urol       Date:  2017-10

8.  High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis.

Authors:  Yohann Rouscoff; Alexander Tuan Falk; Matthieu Durand; Jocelyn Gal; Marie-Eve Chand; Mathieu Gautier; Alexandre Marsaud; Daniel Chevallier; Jean Amiel; Jean-Michel Hannoun-Levi
Journal:  Radiat Oncol       Date:  2014-06-19       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.